Skip to main content
PLOS Neglected Tropical Diseases logoLink to PLOS Neglected Tropical Diseases
. 2024 Apr 17;18(4):e0011451. doi: 10.1371/journal.pntd.0011451

Perceived needs of disease vector control programs: A review and synthesis of (sub)national assessments from South Asia and the Middle East

Henk van den Berg 1, Kabirul Bashar 2, Rajib Chowdhury 3,4, Rajendra M Bhatt 5, Hardev Prasad Gupta 6, Ashwani Kumar 7,8, Shanmugavelu Sabesan 7, Ananganallur N Shriram 7, Hari Kishan Raju Konuganti 7, Akhouri T S Sinha 9, Mohammad Mehdi Sedaghat 10, Ahmadali Enayati 11, Hameeda Mohammed Hassan 12, Aishath Shaheen Najmee 13, Sana Saleem 13, Surendra Uranw 14, Pahalagedera H D Kusumawathie 15, Devika Perera 15, Mohammed A Esmail 16, Lauren B Carrington 17, Samira M Al-Eryani 18, Roop Kumari 19, Bhupender N Nagpal 20, Sabera Sultana 4, Raman Velayudhan 21, Rajpal S Yadav 21,22,*
Editor: Philip J McCall23
PMCID: PMC11075900  PMID: 38630832

Abstract

Systems for disease vector control should be effective, efficient, and flexible to be able to tackle contemporary challenges and threats in the control and elimination of vector-borne diseases. As a priority activity towards the strengthening of vector control systems, it has been advocated that countries conduct a vector-control needs assessment. A review was carried out of the perceived needs for disease vector control programs among eleven countries and subnational states in South Asia and the Middle East. In each country or state, independent teams conducted vector control needs assessment with engagement of stakeholders. Important weaknesses were described for malaria, dengue and leishmaniases regarding vector surveillance, insecticide susceptibility testing, monitoring and evaluation of operations, entomological capacity and laboratory infrastructure. In addition, community mobilization and intersectoral collaboration showed important gaps. Countries and states expressed concern about insecticide resistance that could reduce the continued effectiveness of interventions, which demands improved monitoring. Moreover, attainment of disease elimination necessitates enhanced vector surveillance. Vector control needs assessment provided a useful planning tool for systematic strengthening of vector control systems. A limitation in conducting the vector control needs assessment was that it is time- and resource-intensive. To increase the feasibility and utility of national assessments, an abridged version of the guidance should focus on operationally relevant topics of the assessment. Similar reviews are needed in other regions with different contextual conditions.

Author summary

Vector control can play a major role in the control and elimination of vector-borne diseases, such as malaria, dengue, leishmaniases and other vector-borne diseases. However, to reach its potential, national vector control systems should be adequately supported by vector surveillance, community participation and intersectoral collaboration. As a step towards strengthening vector control, it has been advocated that countries conduct a vector-control needs assessment. The authors reviewed the needs or gaps as perceived by stakeholders of disease vector control programs in eleven countries and subnational states in South Asia and the Middle East. Programs for control and elimination of malaria, dengue and leishmaniases had major shortcomings in vector surveillance and entomological capacity. This was a concern because vectors develop insecticide resistance which, if unchecked, could reduce the effectiveness of interventions. Also, attaining elimination of disease demands enhanced vector surveillance support. There were major gaps in community mobilization and intersectoral collaboration. The findings imply that vector control systems should adapt to the changing disease situation and adopt a cross-disease mandate. The authors propose improvements to the methods of needs assessment.

Introduction

The global burden caused by vector-borne diseases such as malaria, dengue, lymphatic filariasis and leishmaniases is unacceptably high [1], and people in many parts of the World are at risk of two or more vector-borne diseases [2]. Despite the progress made in some regions with the control and elimination of malaria, visceral leishmaniasis and lymphatic filariasis [35], arboviral diseases such as dengue, chikungunya and Zika virus have recently expanded [68]. The transmission of vector-borne disease pathogens can be suppressed or interrupted by vector control interventions, and vector control has had a demonstrated impact on several vector-borne diseases [911]. Vector control tools that have caused dramatic reductions in malaria, and in some cases also in leishmaniases, are insecticide-treated nets (ITNs) and indoor residual spraying (IRS) [1214]. Another valuable vector control tool is larval source management, which includes source reduction and larviciding, and which can be effective against malaria and dengue in specific settings [15,16].

Contemporary challenges in disease vector control include inadequate political and financial commitment; societal and environmental changes, including unplanned urbanization; emerging diseases and invasive vectors; and the development of insecticide resistance. To reach its full potential, vector control should be supported by a vector surveillance system with adequate entomological expertise, with sufficient participation of communities and collaboration between programs and sectors [10,17]. The Global Vector Control Response 2017–2030, which is based on the concepts of integrated vector management, calls on countries and development partners to strengthen vector control as a fundamental approach to preventing disease and responding to outbreaks [18,19]. The first activity among those prioritized for achieving the targets of the Global Vector Control Response is to have a vector control needs assessment conducted and resource mobilization plans developed by countries. Hence, the vector control needs assessment is seen as a starting point for strengthening national vector control systems.

Needs assessment is a form of strategic planning that is occupied with finding the gaps, called needs, between what currently is and what should ideally be, and that prioritizes those needs to guide decisions about what to do next [20]. Needs assessment thus involves establishing the current situation, the desired situation, and the discrepancy between them. The process of vector control needs assessment was first developed in 2003 at regional level as a tool for understanding current strengths and weaknesses of vector control systems, and thus for programs and governments to take steps to enact improvements. In 2017, WHO published a guidance document for a national vector control needs assessment [21], which was aligned with the framework of the Global Vector Control Response. Vector control needs assessment has been implemented in several countries across regions [22]. However, there has not been a review of the outputs of the vector control needs assessments. Our objective was to review the perceived weaknesses in vector control systems that countries are confronted with, and whether the vector control needs assessment is effective in the identification and prioritization of those weaknesses.

Methods

Selection of countries and states

The WHO South-East Asia and Eastern Mediterranean Regions were selected for this review as regions in which vector control programs have been implemented against vector-borne diseases and as the only regions for which assessment reports were available. Only reports which were based on the 2017 WHO guidance document for a national vector control needs assessment [21] were eligible for selection. Thirteen eligible reports were available; eleven of these were from the subregions of South Asia and the Middle East, and consequently, these subregions were set as the geographic scope of our review; for this reason, the available reports from Morocco and Sudan were excluded. The eleven eligible reports were from Bangladesh, Assam (India), Gujarat (India), Jharkhand (India), Tamil Nadu (India), Islamic Republic of Iran, Iraq, Maldives, Nepal, Sri Lanka, and Yemen. The assessments were conducted at national level except for India, where assessments were conducted at subnational (i.e., federated state) level, because of this country’s large size and population. The four Indian states representing different eco-epidemiological settings and health system capacities of the country had previously been selected by the WHO Regional Office in New Delhi for conducting the needs assessments: (i) Assam, north-eastern India, forest-hill ecosystem with tea gardens and rice agriculture, and with deficient health system capacity; (ii) Gujarat, western India, semi-arid, urban and irrigated plains ecologies, and with a well-developed health system capacity; (iii) Jharkhand, eastern India, forest-tribal dominated hilly ecology, poor socio-economic conditions, with a partly-deficient health system capacity; and (iv) Tamil Nadu, southern India, irrigated rice agriculture and urban settings, with a more advanced health system capacity.

Procedure

The WHO Regional Offices in New Delhi and Cairo requested WHO Country Offices in the selected countries to engage national consultants in each country/state, with one or two national consultants per country/state. The national consultants were selected based on their vector control expertise and their familiarity with the national or subnational systems of vector control. The assessments were conducted in 2018–2021, depending on the country/state (Table 1). The tool used by the national consultants for their assessment was the WHO guidance document for a national vector control needs assessment, particularly the questionnaire in its annex [21]. The national consultants engaged with a panel of stakeholders in each country/state through interviews and consultation meetings (S1 Appendix) and conducted a desk review of relevant reports and publications. The results of this process were documented by the national consultants in a report from each country/state. Hence, eleven reports were produced by the selected countries/states, which were submitted via WHO country offices to the authors (S2 Appendix). As a follow-up to the reports, we solicited responses to our specific queries to verify or supplement the information provided in the reports. We also consulted available national strategic plans for malaria, visceral leishmaniasis, dengue and lymphatic filariasis from Bangladesh, India, Sri Lanka, and Nepal.

Table 1. Details per country/state regarding diseases for which a vector control component existed.

Country/state Population (mln)a Disease Disease form Disease deathsb Disease casesb 5-yr change in disease cases (%)b Intervention typec Assessment yeard
Bangladesh 166 Malaria 9 17225 -70 2,3,4 2020
Dengue 179 101354 >+1000 1,2,5 2020
Leishmaniasis Visceral 5 216 -80 4 2020
India/Assam 31 Malaria n/a 1459 -87 3,4 2020
Dengue 0 196 +131 1,2,5 2020
India/Gujarat 60 Malaria 1 13883 -66 2,3,4,5 2020
Dengue 17 18455 +230 1,2,5 2020
India/Jharkhand 33 Malaria 2 37063 -64 3,4 2020
Dengue 1 463 >+1000 1,2 2020
Leishmaniasis Visceral 0 541 -57 4 2020
India/Tamil Nadu 72 Malaria n/a 2088 -63 2,3,4 2020
Dengue 5 8527 +237 1,2,5 2020
Iran 87 Malaria 0 0 -∞ 2,3,4,5 2018
Leishmaniasis Cutaneous / visceral n/a 8161 / 72 -49 / +177 6 2018
Iraq 44 Leishmaniasis Cutaneous / visceral n/a 7056 / 170 +162 / -53 3,4,6 2018
Maldives 1 Dengue 2 5022 n/a 1,2,5 2020
Nepal 29 Malaria 0 464 -91 3,4 2021
Dengue 6 14662 n/a 1 2021
Leishmaniasis Visceral n/a 185 -41 4 2021
Sri Lanka 22 Malaria 0 0 0 2,3,4 2020
Dengue n/a 105049 +121 1,2,4,5 2020
Yemen 32 Malaria 2108 831533 +42 3,4 2018

a Total population; data sources: Federated states of India [26]; other countries [27].

b Annual number of disease deaths and disease cases in 2019, and the change in disease cases over the period 2014–2019 (see Methods). N/a, not available.

c Vector control interventions: 1, Source reduction or environmental management; 2, larviciding; 3, insecticide-treated nets; 4, indoor residual spraying; 5, space spraying (fogging); 6, rodent control.

d Year of completion of the vector control needs assessment.

Analytical framework

We developed an analytical framework, based on available logic models [23], for evaluating the process and results of the vector control needs assessment. The framework consisted of a ‘results chain’ and a comparison between the current and desired situation at each stage of the results chain (Fig 1). The results chain shows the flow from inputs and activities (the ‘means’) of a program to outputs, outcomes, and impact (collectively the ‘results’). The topics pertaining to each step in the results chain were aligned with the framework of the Global Vector Control Response [18]. Programs require input in terms of capacity building, research, human resources, financial resources, and infrastructure. These inputs are used for four types of activities of (i) scaling up and integration of interventions; (ii) surveillance and monitoring & evaluation (M&E); (iii) community mobilization; and (iv) intra/intersectoral collaboration. The inputs and activities are influenced by the enabling factors, most directly by the availability of national strategic plans, guidelines, and organizational structures. The activities give rise to outcomes, such as reduced vector populations or reduced pathogen transmission rates. Finally, the outcomes contribute to impact in terms of a reduction in disease incidence.

Fig 1. Analytical framework for vector control needs assessment, based on available logic models, and aligned to the Global Vector Control Response 2017–2030.

Fig 1

Needs assessment starts from what we want to achieve in terms of impact. The needs are the gaps in the performance or conditions of a program, which is, the gaps between the current situation and the desired situation [24]. When a gap is identified between the current impact and the desired impact, this could expose possible gaps lower down the results chain, in terms of outcomes, activities, inputs and enabling factors of a program [23]. For example, the gap between the current disease situation and the desired disease situation, as defined in national strategic plans, could be caused by ineffective vector control, poor coverage with interventions, or poor compliance by communities, which may be attributable to inadequate inputs or lack of a strategic plan.

Data processing and analysis

For each country/state, the diseases with a programmatic vector control component were identified. Diseases for which a program or a vector control component was lacking in a country/state were omitted from the analysis for that country/state. For each disease, we took the annual number of deaths and indigenous cases in 2019. We also took the five-year change (%) in disease cases since 2014, as an indication of programmatic impact on disease in recent years at country or state level; for Jharkhand, dengue case data were available for the period 2013–2018. The data on deaths and cases were obtained from the reports and follow-up consultation. Gaps in data on deaths and cases were supplemented, where needed, from other sources, specifically malaria case data from Iran, Nepal and Yemen [3], and leishmaniases case data from Iran, Iraq and Nepal [25]. In post-elimination settings, we refer to indigenous cases only.

Categories and key items of a vector control system were construed according to the analytical framework (see descriptions in the S1 Table) and were listed by country/state and disease in a matrix format. The perceptions about the situation and needs of the vector control systems by the national consultants and stakeholders were extracted and interpreted from each report by one of us (HvdB). Based on the narratives in the reports, we appraised and categorized the perceived needs regarding each key item as (a) ‘adequate’ (i.e., no immediate need for improvement), (b) ‘partly adequate’ (i.e., basic item in place but need to be upgraded or updated), (c) ‘inadequate or absent’ (i.e., clear need for improvement), or no information provided which we processed as missing data. These categorized results were used to populate the matrix to provide an overview of the perceived needs per disease per country/state. We then reviewed the results by comparing the key items across countries/states, and between diseases, and by examining the full set of key items per country/state.

A pooled analysis of the perceptions across countries/states was conducted per category and per disease. The purpose of this analysis was to study the average and variability of results in the set of (sub)national assessments, while noting that substantial differences in size, population and vector control conditions exist between countries/states. Numeric values of +1, 0, and -1 were assigned to the categorization as ‘adequate’, ‘partly adequate’ and ‘inadequate or absent’, respectively. For each disease (malaria, dengue, and leishmaniases), average numeric values of key items per category were synthesized, first, per country/state and then, across countries/states, with standard error given as an estimate of variability between countries/states. The numerical data used in Fig 2 are included in the S1 Data.

Fig 2. Synthesis of the perceptions of vector control systems for malaria, dengue and leishmaniases (A-C). Presented is the average score with standard error per category across countries/states (n = 9, 8 and 5 countries/states for malaria, dengue and leishmaniases, respectively), as explained in the Methods. A score of 1 indicates ‘adequate’; -1 indicates inadequate.

Fig 2

Results

We present the results from the eleven countries/states as follows. We first discuss the state of the art of vector control for each disease per country/state. We then present the results of the (sub)national assessments on perceptions regarding malaria, dengue and leishmaniases in separate sections on (a) impact and outcomes, (b) activities, (c) inputs, and (d) enabling factors. Finally, we provide a synthesis of results across countries/states.

Vector control state of the art

Among the eleven selected countries/states, a programmatic vector control component was existent in nine countries/states for malaria; in eight for dengue; and in five for cutaneous and visceral leishmaniases (Table 1). The number of country/states with an existent vector control component for one, two, and three diseases was three, five, and three country/states, respectively. The main vector control intervention types used were ITNs, IRS and larviciding against malaria; source reduction or environmental management, larviciding and space spraying against dengue; and IRS, ITNs and rodent control against leishmaniases (Table 1).

Data on the use of vector control insecticide products were mostly absent from the assessment reports but a recent WHO study found that vector control insecticide use in the Asia-Pacific Region consisted mostly of pyrethroids and organochlorines for the control of malaria and leishmaniasis, and pyrethroids and organophosphates for the control of dengue [28]. Several countries/states expressed concern about the development of insecticide resistance in disease vectors of malaria, dengue and leishmaniases, but data on insecticide susceptibility testing were not systematically reported.

No separate vector control component existed for chikungunya while several reports indicated that vector control for chikungunya was integrated with that for dengue; these viruses are transmitted by the same aedine vector species. Control or elimination of Japanese encephalitis and lymphatic filariasis relied on targeted vaccination, and mass drug administration with case management, respectively, but did not generally include a programmatic vector control component. Exceptions were occasional space spraying operations in villages with positive case reporting of Japanese encephalitis in Tamil Nadu; and larviciding, sanitation and space spraying in urban areas for control of nuisance mosquitoes which include lymphatic filariasis vectors in three countries/states. In Iran, tick control measures were carried out in response to sporadic human cases of Crimean-Congo haemorrhagic fever; however, these measures were implemented by the agriculture ministry, not the health ministry. In Yemen, malaria, dengue, schistosomiasis, leishmaniasis, and onchocerciasis were all endemic, but details about a programmatic vector control component were only reported for malaria, except that it was mentioned that fogging and chemical larviciding have been used in response to dengue outbreaks. The reports from Nepal and Tamil Nadu called for future attention to mite- and tick-borne diseases, for control of scrub typhus (Nepal; Tamil Nadu) and Kyasanur forest disease (Tamil Nadu). Hence, in some countries/states, the absence of vector control for certain diseases could signify the need for establishing a vector control component.

(Sub)national assessments

Impact and outcomes

Starting from the impact level, it is important to know whether the perceptions of impact and outcomes of the operations have been adequate or not, when compared with targets in the available strategic plans. However, none of the countries or states compared the disease situation and trends with the milestones and targets outlined in previous disease-specific strategic plans. Instead, we extracted the perceptions of programmatic impact on disease from the narratives in the reports. The impact on malaria was perceived as ‘adequate’ in eight countries/states (Table 2), as supported by the 63–91% reductions in malaria cases recorded over the period 2014–2019 (Table 1). An exception was Yemen, where an increase in malaria cases in recent years was associated with the severe implications of the civil conflict on the functions of the health sector. Iran achieved zero indigenous malaria cases since 2018. Sri Lanka was certified malaria-free in 2016 and maintained zero indigenous malaria cases in recent years, indicating that the prevention of re-establishment had been effective.

Table 2. Overview of perceptions about the system for malaria vector control.a.
 Key itemb Bangladesh India/ Assam India/ Gujarat India/ Jharkhand India/Tamil Nadu Iran Nepal Sri Lanka Yemen
IMPACT & OUTCOMES:
 Disease impact
 Vector outcomes
ACTIVITIES:
a. Scaling-up, integrating vector control:
 Coverage
 Operational quality
 Pesticide management
b. Vector surveillance and M&E:
 Routine entomological surveys
 Routine insecticide susceptibility tests
 Sentinel sites
 M&E of operations
 Data management and sharing
c. Community mobilization:
 Systematic implementation
 Monitoring
d. Intra/intersectoral collaboration:
 Cross-disease collaboration
 Intersectoral committee
 Intersectoral action
INPUTS:
 Entomologists
 Vector control operators
 Training, entomology
 Training, operations
 Entomology laboratories
 Research input
ENABLING FACTORS:
 Strategic plans
 Guidelines
 Organizational structure

a Perceptions, as described in the text, are categorized as (a) adequate, shaded green; (b) partly adequate, shaded orange (e.g., need to be upgraded or updated); (c) inadequate or absent, shaded red; or (d) no information provided, no shading.

b Key items are described in the S1 Table.

The impact of vector control interventions on dengue was perceived as ‘inadequate’ in all eight countries/states with a dengue vector control component (Table 3), as demonstrated by the sharp increases in dengue cases over the previous five years (Table 1). The impact on leishmaniases was perceived as ‘adequate’ in four countries/states and as ‘inadequate’ in one country with a leishmaniases vector control component (Table 4); the leishmaniases cases over the period 2014–2019 showed marked reductions in most instances, but Iraq and Iran, where both forms of leishmaniases were present, showed recent increases in cutaneous and visceral leishmaniasis, respectively (Table 1).

Table 3. Overview of perceptions about the system for dengue vector control.a.
CATEGORY
Key itemb
Bangladesh India/ Assam India/ Gujarat India/ Jharkhand India/Tamil Nadu Maldives Nepal Sri Lanka
IMPACT & OUTCOMES:
 Impact on disease
 Vector outcomes
ACTIVITIES:
a. Scaling-up, integrating vector control:
 Coverage
 Operational quality
 Pesticide management
b. Vector surveillance and M&E:
 Routine entomological surveys
 Routine insecticide susceptibility tests
 Sentinel sites
 M&E of operations
 Data management and sharing
c. Community mobilization:
 Systematic implementation
 Monitoring
d. Intra/intersectoral collaboration:
 Cross-disease collaboration
 Intersectoral committee
 Intersectoral action
INPUTS:
 Entomologists
 Vector control operators
 Training, entomology
 Training, operations
 Entomology laboratories
 Research input
ENABLING FACTORS:
 Strategic plans
 Guidelines
 Organizational structure

a Perceptions, as described in the text, are categorized as (a) adequate, shaded green; (b) partly adequate, shaded orange; (c) inadequate or absent, shaded red; or (d) no information provided, no shading.

b Key items are described in the S1 Table.

Table 4. Overview of perceptions about the system for leishmaniases vector control.a.
CATEGORY
Key itemb
Bangladesh India/ Jharkhand Iran Iraq Nepal
IMPACT & OUTCOMES:
 Impact on disease
 Vector outcomes
ACTIVITIES:
a. Scaling-up, integrating vector control:
 Coverage
 Operational quality
 Pesticide management
b. Vector surveillance and M&E:
 Routine entomological surveys
 Routine insecticide susceptibility tests
 Sentinel sites
 M&E of operations
 Data management and sharing
c. Community mobilization:
 Systematic implementation
 Monitoring
d. Intra/intersectoral collaboration:
 Cross-disease collaboration
 Intersectoral committee
 Intersectoral action
INPUTS:
 Entomologists
 Vector control operators
 Training, entomology
 Training, operations
 Entomology laboratories
 Research input
ENABLING FACTORS:
 Strategic plans
 Guidelines
 Organizational structure

a Perceptions, as described in the text, are categorized as (a) adequate, shaded green; (b) partly adequate, shaded orange; (c) inadequate or absent, shaded red; or (d) no information provided, no shading.

b Key items are described in the S1 Table.

Outcomes of vector control operations typically include changes in vector densities, biting rates, or transmission rates that are not due to seasonality. Outcome assessment can enable the evaluation of whether vector control has or has not been effective. None of the countries or states reported that such entomological outcomes were available or that they were used for evaluation of vector control for malaria, dengue or leishmaniases, suggesting this issue requires further attention.

Activities

a. Scaling-up, integrating vector control: The reports provided few details regarding the implementation of vector control, the quality of interventions, timing, stratification and targeting of interventions, and whether implementation was in accordance with national strategic and operational plans. The coverage of populations with vector control interventions was perceived as ‘adequate’ or ‘partly adequate’ for malaria and leishmaniases but was considered only ‘partly adequate’ for dengue. Operational quality was not reported on, except by Iran and the Maldives. With regard to pesticide management, the four Indian states reported that national guidelines on pesticide management were followed by the programs; the seven other countries described shortcomings in pesticide management regarding training on safe handling, personal protection, safe storage, or regulation.

b. Vector surveillance and M&E: Critical shortcomings were reported regarding routine entomological surveys for malaria, with major differences reported between countries/states (Table 2). In most cases, surveillance of malaria vectors was patchy or irregular due to shortcomings in entomological capacity, including entomologists, technicians, and equipment; or surveillance covered only few entomological parameters. Exceptions were Sri Lanka and Iran where malaria vector surveillance was appraised as ‘adequate’. Routine insecticide susceptibility testing of malaria vectors was perceived as ‘inadequate’ or ‘partly adequate’ in seven out of nine malaria programs (Table 2). Similarly, inadequacies were reported for the presence of sentinel sites, which are needed for monitoring temporal changes in entomological parameters. The monitoring and evaluation (M&E) of malaria vector control operations was perceived as ‘inadequate’ in three countries/states. Five out of eight countries/states reported adequate data management and data sharing on malaria vector surveillance and control. For dengue and leishmaniases, the perceived situation on vector surveillance and M&E was similar to malaria, except in Sri Lanka and Iran, where it was perceived as inferior to that for malaria (Tables 3 and 4). In none of the countries/states, routine insecticide susceptibility testing of dengue or leishmaniases vectors was considered as ‘adequate’. It was noted from Tamil Nadu that vector surveillance was particularly weak in urban centers, where most malaria and dengue cases occurred.

c. Community mobilization: Systematic implementation of community mobilization was considered to be ‘adequate’ in only a minority of the programs on malaria, dengue and leishmaniases (Tables 24). Reported community mobilization activities included campaigns, school rallies, house-to-house visits, and use of media, intended to promote disease prevention, health-seeking behavior, and compliance with interventions. In most programs on malaria, dengue and leishmaniases, the monitoring of community mobilization was reported to be ‘absent’ or ‘partly adequate’, or no information was provided (Tables 24).

d. Intra- and intersectoral collaboration: The collaboration on vector control between disease control programs was perceived as ‘adequate’ in the four Indian states because all vector-borne diseases were operated under one national umbrella program with a cross-disease mandate (Tables 24). In Nepal and Iraq, a single vector control unit was present at national level to oversee all vector-borne diseases. In Sri Lanka, the malaria program and the dengue program collaborated on vector surveillance and vector control at the district level. Lack of coordination between vector control programs was reported from Bangladesh and Yemen.

Establishment of an intersectoral committee or task force can facilitate multisectoral engagement in vector control across diseases [18]. Functional committees were ‘adequate’ in less than half of the malaria programs but were more common in dengue programs because the committees in Bangladesh and Sri Lanka focused on dengue only (Tables 24). Intersectoral action on vector control was perceived as ‘inadequate’ or ‘absent’ in most programs (Tables 24). Hence, the presence of a committee was no assurance for intersectoral action, as was apparent in Bangladesh, Jharkhand, Iraq, and Nepal. In Iran, the malaria program collaborated with a provincial water and wastewater company to repair broken water pipes to contain breeding sites of malaria vectors. In Sri Lanka, cleaning campaigns for dengue control involved collaboration of the dengue program at decentralized level with the police, armed forces, local government, and community leaders.

Inputs

As inputs, we considered human resources, in terms of entomologists, and vector control operators (spray workers; supervisors); capacity building, in terms of training on entomology and operations; infrastructure, in terms of entomology laboratories; and research input. Financial inputs were excluded from our evaluation. Entomological capacity and expertise were perceived as ‘inadequate’ or ‘partly adequate’ in nearly all malaria programs, and in all dengue and leishmaniases programs (Tables 24). Exceptions were Sri Lanka and Yemen, where the perception was that adequate entomologists were available for prevention and control of malaria. The shortage of entomologists in the four Indian states and in Bangladesh was primarily caused by high levels of vacancies. The reports of Bangladesh and Gujarat specified the lack of promotional avenues for entomologists as a possible cause of vacancies. Vector control operators were perceived as ‘adequate’ or ‘partly adequate’ in most programs.

Training in entomology, including in vector surveillance and decision making on vector control, was perceived as ‘inadequate’ or ‘partly adequate’ in all but one malaria program and in all dengue and leishmaniases programs. An exception was Sri Lanka, where training requirements for malaria entomology were adequately adjusted to the prevention of re-establishment phase. Training on operations also showed shortcomings in several programs (Tables 24). Entomology laboratories, which are needed for processing of field samples, insecticide susceptibility testing, and operational studies, were perceived as ‘adequate’ in three out of nine malaria programs, one out of eight dengue programs, and two out of five leishmaniases programs (Tables 24).

Research input for vector control was perceived as ‘inadequate’ or ‘partly adequate’ in all but one program (Tables 24). Weaknesses were reported in the coordination or prioritization of research for operational relevance, and the lack of data sharing between research and operations. The report from Tamil Nadu highlighted the specific need for research on integrated control of Anopheles stephensi and Aedes aegypti in urban environments, and research on control options for neglected but emerging mite- and tick-borne diseases, such as scrub typhus and Kyasanur forest disease.

Enabling factors

We reviewed the availability of national strategic plans, national guidelines, and organizational structures as enabling factors for vector surveillance and vector control. National strategic plans were ‘adequate’ for all malaria programs, five out of eight dengue programs and four out of five leishmaniases programs. National guidelines on vector control were ‘adequate’ in most programs on malaria, dengue and leishmaniases.

The reports from most countries/states noted that an ‘adequate’ or ‘partly adequate’ organizational structure was in place defining roles, responsibilities, and lines of reporting on vector control. Most dengue programs were decentralized to the municipalities and districts, but the Maldives noted the roles and responsibilities regarding vector control had not been defined at decentralized level, whilst in Nepal, recent federalization of the government system negatively affected the vector surveillance and control activities.

The reports elaborated on policies that might support or conflict with disease vector control. However, this rich and complex information was not amenable to be categorized as ‘adequate’, ‘partly adequate’ or ‘inadequate’. All countries/states listed policies available in other sectors with relevance for vector control. Examples are a policy on solid waste management, policy on pollution abatement in rivers and lakes, policy on environmental impact assessment of new projects, policy on integrated pest management in agriculture, regulation on prevention of mosquito breeding, and policy on international health regulations at points of entry.

Synthesis

The analysis of the perceived situation captured the results per category across countries/states (Fig 2). The impact on disease was perceived as ‘adequate’ for malaria and leishmaniases, indicated by a score approaching the value of 1, but ‘inadequate’ for dengue, indicated by a score of -1. Scaling-up of interventions was perceived as moderately adequate (0.23–0.46) for the three diseases, but with substantial variation between countries/states. The score for vector surveillance and M&E was negative for all diseases, especially for dengue and leishmaniases, indicating it was ‘inadequate’ or ‘partly adequate’. The scores for community mobilization were also marginally negative for all diseases, whilst the score for intra/intersectoral collaboration was marginally negative for malaria, neutral for leishmaniases, and positive for dengue. The score for inputs, in terms of human resources, capacity building, infrastructure and research, was neutral or marginally negative for the three diseases. The enabling factors, in terms of suitable strategies, guidelines and organizational structure, scored distinctly positive for the three diseases.

Most of the reports contained a concluding section in which what were conceived as priority needs were listed, the most frequent of which referred to the improvement of vector surveillance and insecticide resistance monitoring; the strengthening of entomological expertise, equipment and laboratory infrastructure; the establishment of an intersectoral committee on integrated vector management; and enhancement of research inputs.

The reports also discussed contemporary or future challenges to vector control. First, concern about the development of insecticide resistance in disease vectors of malaria, dengue and leishmaniases was expressed in the reports from Gujarat, Jharkhand, Bangladesh and Sri Lanka. The second challenge was to attain and maintain disease elimination. For example, the report from Tamil Nadu highlighted the need for enhanced vector surveillance owing to the role of the partly outdoor biting behavior of An. culicifacies and An. stephensi in maintaining residual malaria transmission, including in urban centers. In the four Indian states, filling the vacant entomology posts was deemed necessary for eliminating malaria. It was reported from Sri Lanka that a financial transition has been adopted to ensure that the malaria-free status is sustained. A third challenge was reported regarding the emergence of vector-borne diseases and invasive vector species, including the geographic expansion, and increasing incidence of arboviral diseases in the subregions.

Discussion

National or subnational systems of disease vector control comprise technical, logistical, and institutional elements for the control, elimination or prevention of multiple vector-borne diseases. Understanding the functioning of these systems within dynamic epidemiological, socio-economic, and environmental settings is vital to ensure cost-effective, efficient, and adaptive implementation of vector control. The WHO guidance document for a national vector control needs assessment was intended as a tool to help countries analyze their vector control systems and propose structural improvements [21]. Evidently, use of the tool through multistakeholder consultations enabled the selected countries/states to identify critical shortcomings and needs. The results disclosed a mixed picture of the situation of vector control systems, with large differences between countries/states. Important weaknesses were described for malaria, dengue and leishmaniases regarding vector surveillance, insecticide susceptibility testing, M&E of operations, entomological expertise and laboratory infrastructure. In addition, community mobilization and intersectoral collaboration, which have been advocated as pillars of action in the Global Vector Control Response [18], exposed important gaps. There has been a shortage of international resources to support national vector control systems [29]. Substantial investment will be needed in most of the countries/states to strengthen their capacity for vector surveillance and insecticide resistance monitoring using domestic and international funding sources.

Entomological capacity was identified as a scarce asset, and in some countries, the available capacity was disease-specific and not shared for the control of other vector-borne diseases. Recruitment of entomologists, training and strengthening of laboratory infrastructure are urgently needed as inputs for strengthening the vector control systems. Moreover, the collaboration between vector control programs through establishment of a vector control unit with cross-disease mandate has potential to improve efficiency through the sharing of entomological expertise, capacity and vector control resources [30], considering that some diseases may be eliminated while others are emerging.

Despite the positive programmatic impact on malaria and visceral leishmaniasis with the use of ITN and IRS interventions, countries/states expressed concern about contemporary and future challenges that could reduce the continued effectiveness of these interventions and, thus, undermine efforts to attain national targets for disease control and elimination. Vectors can adapt to the use of ITNs and IRS by developing insecticide resistance, behavioral resistance, or by changing their species composition [3133]; hence, strong vector surveillance is essential for timely detection of such changes to trigger an appropriate response regarding the selection and use of vector control tools and products.

In dengue control, an additional challenge has been the lack of effective control tools, especially in the absence of medications or vaccines that tackle the reservoir of dengue virus. Most of the available dengue vector control tools have been developed in an era when epidemiological outcomes were not emphasized in the assessment of efficacy [34]. Moreover, it has proven difficult in urbanized areas to achieve and sustain high coverage of breeding sites with source reduction and larviciding over the length of the transmission season [35]; this was reflected in our review by shortcomings in community mobilization and operational coverage of dengue vector control.

Another challenge faced by the countries was to attain or maintain disease elimination. When transmission nears zero, intensified epidemiological and entomological surveillance is needed for fine-grained stratification of at-risk areas, with identification of hotspots, to improve the targeting of operations. Moreover, at low transmission rates it will be vital to understand and control the sources of residual transmission which could, for example, be due to outdoor biting of malaria vectors when ITNs or IRS are the vector control tools relied upon for malaria elimination [36]. In this context, it is acknowledged that Sri Lanka and Iran, the two selected countries that recently achieved zero indigenous malaria cases, reported above-average conditions of malaria vector surveillance.

A strength of our paper is that it reviewed the comprehensive situation of vector control systems at national and subnational level, highlighting elements that require further attention. Our analysis indicated that, in most cases, capacity building, institutional change, and resource mobilization were key priorities that would enable a greater impact of vector control. The results can inform international agencies about the need to provide support on certain key items at subregional level, for example, through regional training courses, or to assist selected countries with their strengthening of vector control systems.

Moreover, our review provided much-needed insights into the use of the WHO guidance document for a national vector control needs assessment. The Global Vector Control Response recommended that vector-borne disease-endemic countries conduct a national vector control needs assessment and resource mobilization plan [18]. However, in 2021, only 27% of countries had completed a vector control needs assessment using the 2017 WHO guidance document [22]. We note that all assessments in our review were conducted with external financial support for national consultants and stakeholder meetings. Clearly, a limitation in conducting a (sub)national vector control needs assessment has been the time and resources required. The 2017 WHO guidance document covered topics with immediate relevance to operational programs and broader topics that are indirectly relevant to the subject matter. The latter, including policy matters, have taken a substantial part of the time and effort of the selected assessments.

To increase the feasibility and utility of national assessments, an abridged version of the guidance should be developed that is focused on operationally relevant topics. In the interim, we suggest that countries with time and resource restrictions select only those questions from the WHO guidance document that are linked to the topics of operational relevance, as presented in Fig 1. Moreover, the methods for needs assessment should be enhanced, to make comparison between the current versus the desired situation for more precise identification of needs, and to include a process of prioritization of needs with causal analysis along the results chain; for example, by assigning weight to each need and exploring the cost of addressing the need versus the cost of inaction. The needs assessment should be complemented by guidance on resource mobilization planning. We further recommend the evaluation of whether vector control needs assessment leads to structural improvements in vector control systems over time.

Our review had several important limitations. The assessment in each country/state was conducted by a different team, which presented a source of variation in the reports. Our assignment of categories for the appraisal of perceptions was dependent on the narratives in the reports and the follow-up responses. In future, the appraisal of perceptions could potentially be simplified if the responses to the assessment’s questions are provided in a standardized format, as the ‘raw information’ on which the narrative report is based. A limitation in the synthesis of results was the disparities in size, population and vector control conditions between countries/states. Our results probably have limited generalizability beyond South Asia and the Middle East because of differences in the disease situation, vector biology, regional strategies, and support mechanisms. This suggests that similar reviews are needed in other regions.

Copyright statement

2024 World Health Organization. Licensee Public Library of Science. This is an open access article distributed under the Creative Commons Attribution IGO License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited: https://creativecommons.org/licenses/by/3.0/igo/. In any use of this article, there should be no suggestion that WHO endorses any specific organization, products or services.

Supporting information

S1 Appendix. Panel of stakeholders involved in vector control needs assessment in each country/state.

(DOCX)

pntd.0011451.s001.docx (22.5KB, docx)
S2 Appendix. List of vector control needs assessment reports, by country, with availability from third party sources.

(DOCX)

pntd.0011451.s002.docx (18.7KB, docx)
S1 Table. Description of the key items of the vector control system.

(DOCX)

pntd.0011451.s003.docx (22KB, docx)
S1 Data. Table containing the underlying numerical data for Fig 2.

(DOCX)

pntd.0011451.s004.docx (21.2KB, docx)

Acknowledgments

WHO thanks Dr Subhash Lakhe, WHO Country Office, Kathmandu for facilitating the study in Nepal and gratefully acknowledges the technical inputs by stakeholders in their respective countries/states.

Disclaimer

The authors alone are responsible for the views expressed in this article and they do not necessarily represent the views, decisions or policies of the institutions with which they are affiliated.

Data Availability

The data contained in the reports on which this work was based cannot be shared because they are property of third parties and the informed consent did not include the permission. The reports can be requested from the third-party sources listed in the S2 Appendix by researchers who meet the criteria for access to confidential data.

Funding Statement

The work was supported partly by the Bill & Melinda Gates Foundation, Seattle, WA, USA under the Innovation-2-Impact project (grant number OPP1133139) awarded to the World Health Organization (RV and RSY), and partly by the WHO Global Malaria Programme (internal funds). The former funder had no role in design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Kyu HH, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392(10159):1859−922. doi: 10.1016/S0140-6736(18)32335-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Golding N, Wilson AL, Moyes CL, Cano J, Pigott DM, Velayudhan R, et al. Integrating vector control across diseases. BMC Medicine. 2015; 13(1):249. doi: 10.1186/s12916-015-0491-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.WHO. World malaria report 2022. Geneva: World Health Organization; 2022. Available from: https://iris.who.int/handle/10665/365169.
  • 4.Deshpande A, Miller-Petrie MK, Lindstedt PA, Baumann MM, Johnson KB, Blacker BF, et al. The global distribution of lymphatic filariasis, 2000–18: a geospatial analysis. Lancet Global Health. 2020; 8(9):e1186−e94. doi: 10.1016/S2214-109X(20)30286-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.WHO. Global leishmaniasis surveillance: 2021, assessing the impact of the COVID-19 pandemic–Surveillance mondiale de la leishmaniose: 2021, évaluation de l’impact de la pandémie de COVID-19. Weekly Epidemiological Record = Relevé épidémiologique hebdomadaire. 2022; 97(45):575−90. Available from: https://iris.who.int/handle/10665/364350.
  • 6.Brady OJ, Hay SI. The global expansion of dengue: How Aedes aegypti mosquitoes enabled the first pandemic arbovirus. Annual Review of Entomology. 2020;65:191−208. doi: 10.1146/annurev-ento-011019-024918 [DOI] [PubMed] [Google Scholar]
  • 7.Puntasecca CJ, King CH, LaBeaud AD. Measuring the global burden of chikungunya and Zika viruses: A systematic review. PLoS Neglected Tropical Diseases. 2021; 15(3):e0009055. doi: 10.1371/journal.pntd.0009055 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Yang X, Quam MB, Zhang T, Sang S. Global burden for dengue and the evolving pattern in the past 30 years. Journal of Travel Medicine. 2021; 28(8):taab146. doi: 10.1093/jtm/taab146 [DOI] [PubMed] [Google Scholar]
  • 9.Wilson AL, Courtenay O, Kelly-Hope LA, Scott TW, Takken W, Torr SJ, et al. The importance of vector control for the control and elimination of vector-borne diseases. PLoS Neglected Tropical Diseases. 2020; 14(1):e0007831. doi: 10.1371/journal.pntd.0007831 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Townson H, Nathan MB, Zaim M, Guillet P, Manga L, Bos R, et al. Exploiting the potential of vector control for disease prevention. Bull World Health Organ. 2005; 83(12):942−7. Available from: https://iris.who.int/handle/10665/269548 [PMC free article] [PubMed] [Google Scholar]
  • 11.Roiz D, Wilson AL, Scott TW, Fonseca DM, Jourdain F, Müller P, et al. Integrated Aedes management for the control of Aedes-borne diseases. PLoS Neglected Tropical Diseases. 2018; 12(12):e0006845. doi: 10.1371/journal.pntd.0006845 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Wilson AL, Dhiman RC, Kitron U, Scott TW, van den Berg H, Lindsay SW. Benefit of insecticide-treated nets, curtains and screening on vector borne diseases, excluding malaria: a systematic review and meta-analysis. PLoS Neglected Tropical Diseases. 2014; 8(10):e3228. doi: 10.1371/journal.pntd.0003228 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Sherrard-Smith E, Griffin JT, Winskill P, Corbel V, Pennetier C, Djénontin A, et al. Systematic review of indoor residual spray efficacy and effectiveness against Plasmodium falciparum in Africa. Nature Communications. 2018; 9(1):1−13. doi: 10.1038/s41467-018-07357-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Bhatt S, Weiss DJ, Cameron E, Bisanzio D, Mappin B, Dalrymple U, et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature. 2015; 526(7572):207−11. doi: 10.1038/nature15535 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Choi L, Majambere S, Wilson AL. Larviciding to prevent malaria transmission. Cochrane Database of Systematic Reviews. 2019; (8). doi: 10.1002/14651858.CD012736.pub2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Buhler C, Winkler V, Runge-Ranzinger S, Boyce R, Horstick O. Environmental methods for dengue vector control–A systematic review and meta-analysis. PLoS Neglected Tropical Diseases. 2019; 13(7):e0007420. doi: 10.1371/journal.pntd.0007420 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Mnzava AP, Macdonald MB, Knox TB, Temu EA, Shiff CJ. Malaria vector control at crossroads: public health entomology and the drive to elimination. Transactions of The Royal Society of Tropical Medicine and Hygiene. 2014; 108(9):550−4. doi: 10.1093/trstmh/tru101 [DOI] [PubMed] [Google Scholar]
  • 18.WHO. Global vector control response 2017–2030. Geneva: World Health Organization; 2017. Available from: https://iris.who.int/handle/10665/259002.
  • 19.WHO. Handbook for integrated vector management. Geneva: World Health Organization; 2012. Available from: https://iris.who.int/handle/10665/44768.
  • 20.Altschuld JW, Watkins R. A primer on needs assessment: More than 40 years of research and practice. New Directions for Evaluation. 2014; 2014(144):5−18. doi: 10.1002/ev.20099 [DOI] [Google Scholar]
  • 21.WHO. Framework for a National Vector Control Needs Assessment. Geneva: World Health Organization; 2017. Available from: https://iris.who.int/handle/10665/259405.
  • 22.WHO. Progress reports. Report by the Director General. G. Global vector control response: an integrated approach for the control of vector-borne diseases (resolution WHA70.16, May 2017). 12 April 2022. 75th World Health Assembly. A75/44. Geneva: World Health Organization; 2022. Available from: https://apps.who.int/gb/ebwha/pdf_files/WHA75/A75_44-en.pdf.
  • 23.Watkins R, Meiers MW, Visser Y. A guide to assessing needs: Essential tools for collecting information, making decisions, and achieving development results: World Bank Publications; 2012. doi: 10.1596/978-0-8213-8868-6 [DOI] [Google Scholar]
  • 24.Kaufman R, Oakley-Browne H, Watkins R, Leigh D. Strategic planning for success: Aligning people, performance, and payoffs: John Wiley & Sons; 2003. ISBN: 0-7879-6503-0. [Google Scholar]
  • 25.WHO. The Global Health Observatory 2023. Available from: https://www.who.int/data/gho/data/.
  • 26.Planning Commission. Census 2011 (PCA—Final Data)—Population, Persons. Planning Commission, Government of India 2011. Available from: https://web.archive.org/web/20180127163347/http://planningcommission.gov.in/data/datatable/data_2312/DatabookDec2014%20307.pdf
  • 27.UN. World Population Prospects 2022 New York: Department of Economic and Social Affairs, Population Division, United Nations; 2023. Available from: https://population.un.org/wpp/
  • 28.van den Berg H, da Silva Bezerra HS, Al-Eryani S, Chanda E, Nagpal BN, Knox TB, et al. Recent trends in global insecticide use for disease vector control and potential implications for resistance management. Scientific Reports. 2021; 11(1):23867. doi: 10.1038/s41598-021-03367-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.WHO. Global vector control response: progress in planning and implementation. Geneva: World Health Organization; 2020. Available from: https://iris.who.int/handle/10665/336658.
  • 30.van den Berg H, Velayudhan R, Yadav RS. Management of insecticides for use in disease vector control: Lessons from six countries in Asia and the Middle East. PLoS Negl Trop Dis. 2021; 15(4):e0009358. doi: 10.1371/journal.pntd.0009358 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.WHO. Malaria treats map. Vector insecticide resistance. Geneva: World Health Organization; 2022. Available from: https://apps.who.int/malaria/maps/threats/.
  • 32.Kreppel K, Viana M, Main B, Johnson P, Govella N, Lee Y, et al. Emergence of behavioural avoidance strategies of malaria vectors in areas of high LLIN coverage in Tanzania. Scientific Reports. 2020; 10(1):1−11. doi: 10.1038/s41598-020-71187-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Russell TL, Beebe NW, Cooper RD, Lobo NF, Burkot TR. Successful malaria elimination strategies require interventions that target changing vector behaviours. Malaria Journal. 2013; 12(1):1−5. doi: 10.1186/1475-2875-12-56 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Achee NL, Gould F, Perkins TA, Reiner RC Jr, Morrison AC, Ritchie SA, et al. A critical assessment of vector control for dengue prevention. PLoS Neglected Tropical Diseases. 2015; 9(5):e0003655. doi: 10.1371/journal.pntd.0003655 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Gubler DJ. Prevention and control of Aedes aegypti-borne diseases: lesson learned from past successes and failures. AsPac J Mol Biol Biotechnol. 2011; 19(3):111−4. [Google Scholar]
  • 36.Durnez L, Coosemans M. Residual transmission of malaria: an old issue for new approaches. In: Manguin S, editor. Anopheles mosquitoes: New insights into malaria vectors. Rijeka, Croatia: IntechOpen; 2013. p. 671−704. doi: 10.5772/55925 [DOI] [Google Scholar]
PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0011451.r001

Decision Letter 0

Philip J McCall, Amy C Morrison

1 Feb 2024

Dear Dr. Yadav,

Thank you very much for submitting your manuscript "Perceived needs of disease vector control programs: A review and synthesis of (sub)national assessments from South Asia and the Middle East" for consideration at PLOS Neglected Tropical Diseases. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations.

Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Philip J McCall

Academic Editor

PLOS Neglected Tropical Diseases

Amy Morrison

Section Editor

PLOS Neglected Tropical Diseases

***********************

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: (No Response)

--------------------

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: (No Response)

--------------------

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: (No Response)

Reviewer #2: Yes though I would like to see more input from the authors based on their experience and their knowledge of the resources needed. without it, the value of the info collected is undermined to some extent.

--------------------

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: (No Response)

Reviewer #2: N/A

--------------------

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: The manuscript explores the perceived needs of disease vector control programs in the South Asia and Middle East zones. Addressing vector control issues is crucial, particularly in regions where vector-borne diseases (VBD) are not yet under control. For those regions where control is established, more surveillance is essential to prevent resurgence. However, the presentation of the paper could be adjusted to better emphasize its contribution in transforming the pooling of country reports on the assessment of vector control needs into a research manuscript.

To enhance the manuscript's value, consider dividing it into two parts. The first part could focus on reviewing the state of the art regarding vector control in the countries covered. Important literature, including information about vector control history, current status, insecticides used, application periods, and resistance to insecticides, may provide a more comprehensive context.

The second part could present the synthesis of the national assessment per country, as it is currently structured. Countries vary in terms of vector control implementation, with only a few having programs for at least one of the three diseases. Table 1 could be more comprehensive by including the number of deaths per country and per disease. Additionally, Graph 2 needs improvement in terms of clarity and legibility. Consider using either colors or letters consistently and ensure that the legend is not redundant. Most of the terminologies and concepts used need clarification (Table 2-4).

The quantitative analysis of perception appears more qualitative, and the significant disparities between these countries raise questions about the added value of pooling data from different countries together.

While acknowledging the limitations of the study is appropriate, consider expanding on them to guide readers on parameters that should be approached with caution, particularly in the synthesis.

Reviewer #2: Viewing the scale involved, the size of the populations of the nations included, the involvement of WHO plus the magnitude/ importance and value of the NTD Information reported, the article would be unusual, but highly appropriate when published in PLOS NTDs.

--------------------

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

References

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article's retracted status in the References list and also include a citation and full reference for the retraction notice.

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0011451.r003

Decision Letter 1

Philip J McCall, Amy C Morrison

26 Mar 2024

Dear Dr. Yadav,

We are pleased to inform you that your manuscript 'Perceived needs of disease vector control programs: A review and synthesis of (sub)national assessments from South Asia and the Middle East' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Philip J McCall

Academic Editor

PLOS Neglected Tropical Diseases

Amy Morrison

Section Editor

PLOS Neglected Tropical Diseases

***********************************************************

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0011451.r004

Acceptance letter

Philip J McCall, Amy C Morrison

12 Apr 2024

Dear Dr. Yadav,

We are delighted to inform you that your manuscript, "Perceived needs of disease vector control programs: A review and synthesis of (sub)national assessments from South Asia and the Middle East," has been formally accepted for publication in PLOS Neglected Tropical Diseases.

We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Appendix. Panel of stakeholders involved in vector control needs assessment in each country/state.

    (DOCX)

    pntd.0011451.s001.docx (22.5KB, docx)
    S2 Appendix. List of vector control needs assessment reports, by country, with availability from third party sources.

    (DOCX)

    pntd.0011451.s002.docx (18.7KB, docx)
    S1 Table. Description of the key items of the vector control system.

    (DOCX)

    pntd.0011451.s003.docx (22KB, docx)
    S1 Data. Table containing the underlying numerical data for Fig 2.

    (DOCX)

    pntd.0011451.s004.docx (21.2KB, docx)
    Attachment

    Submitted filename: Response letter_revised.docx

    pntd.0011451.s005.docx (29.8KB, docx)

    Data Availability Statement

    The data contained in the reports on which this work was based cannot be shared because they are property of third parties and the informed consent did not include the permission. The reports can be requested from the third-party sources listed in the S2 Appendix by researchers who meet the criteria for access to confidential data.


    Articles from PLOS Neglected Tropical Diseases are provided here courtesy of PLOS

    RESOURCES